445 related articles for article (PubMed ID: 20598682)
1. Modulation of the cardioprotective effect of ischemic preconditioning in hyperlipidaemic rat heart.
Yadav HN; Singh M; Sharma PL
Eur J Pharmacol; 2010 Sep; 643(1):78-83. PubMed ID: 20598682
[TBL] [Abstract][Full Text] [Related]
2. Involvement of GSK-3β in attenuation of the cardioprotective effect of ischemic preconditioning in diabetic rat heart.
Yadav HN; Singh M; Sharma PL
Mol Cell Biochem; 2010 Oct; 343(1-2):75-81. PubMed ID: 20512612
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of sphingosine-1-phosphate induced cardioprotection against I/R injury in diabetic rat heart: Possible involvement of glycogen synthase kinase 3β and mitochondrial permeability transition pore.
Rana A; Sharma S
Clin Exp Pharmacol Physiol; 2016 Feb; 43(2):166-73. PubMed ID: 26582369
[TBL] [Abstract][Full Text] [Related]
4. Cardioprotective effect of morphine and a blocker of glycogen synthase kinase 3 beta, SB216763 [3-(2,4-dichlorophenyl)-4(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione], via inhibition of the mitochondrial permeability transition pore.
Obame FN; Plin-Mercier C; Assaly R; Zini R; Dubois-Randé JL; Berdeaux A; Morin D
J Pharmacol Exp Ther; 2008 Jul; 326(1):252-8. PubMed ID: 18434587
[TBL] [Abstract][Full Text] [Related]
5. N6-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide confers cardioprotection at reperfusion by inhibiting mitochondrial permeability transition pore opening via glycogen synthase kinase 3 beta.
Park SS; Zhao H; Jang Y; Mueller RA; Xu Z
J Pharmacol Exp Ther; 2006 Jul; 318(1):124-31. PubMed ID: 16611852
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological inhibition of GSK-3β produces late phase of cardioprotection in hyperlipidemic rat: possible involvement of HSP 72.
Yadav HN; Singh M; Sharma PL
Mol Cell Biochem; 2012 Oct; 369(1-2):227-33. PubMed ID: 22810500
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effect of zinc chloride and zinc ionophore pyrithione on attenuated cardioprotective potential of preconditioning phenomenon in STZ-induced diabetic rat heart.
Jamwal S; Kumar K; Reddy BV
Perfusion; 2016 May; 31(4):334-42. PubMed ID: 26423303
[TBL] [Abstract][Full Text] [Related]
8. Effect of zinc supplements in the attenuated cardioprotective effect of ischemic preconditioning in hyperlipidemic rat heart.
Kansal SK; Jyoti U; Sharma S; Kaura A; Deshmukh R; Goyal S
Naunyn Schmiedebergs Arch Pharmacol; 2015 Jun; 388(6):635-41. PubMed ID: 25743572
[TBL] [Abstract][Full Text] [Related]
9. Effect of pioglitazone on the abrogated cardioprotective effect of ischemic preconditioning in hyperlipidemic rat heart.
Mittal D; Taliyan R; Sharma PL; Yadav HN
Indian J Pharmacol; 2016; 48(1):59-63. PubMed ID: 26997724
[TBL] [Abstract][Full Text] [Related]
10. Adenosine-A1 receptors activation restores the suppressed cardioprotective effects of ischemic preconditioning in hyperhomocysteinemic rat hearts.
Balakumar P; Singh H; Reddy K; Anand-Srivastava MB
J Cardiovasc Pharmacol; 2009 Sep; 54(3):204-12. PubMed ID: 19568176
[TBL] [Abstract][Full Text] [Related]
11. Effect of pressure overload on cardioprotection of mitochondrial KATP channels and GSK-3beta: interaction with the MPT pore.
Mozaffari MS; Schaffer SW
Am J Hypertens; 2008 May; 21(5):570-5. PubMed ID: 18437149
[TBL] [Abstract][Full Text] [Related]
12. Possible role of JAK-2 in attenuated cardioprotective effect of ischemic preconditioning in hyperhomocysteinemic rat hearts.
Singh G; Rohilla A; Singh M; Balakumar P
Yakugaku Zasshi; 2009 May; 129(5):523-35. PubMed ID: 19420883
[TBL] [Abstract][Full Text] [Related]
13. Possible involvement of PKC-delta in the abrogated cardioprotective potential of ischemic preconditioning in hyperhomocysteinemic rat hearts.
Rohilla A; Singh G; Singh M; Bala kumar P
Biomed Pharmacother; 2010 Mar; 64(3):195-202. PubMed ID: 19914792
[TBL] [Abstract][Full Text] [Related]
14. Involvement of atrial natriuretic peptide in abrogated cardioprotective effect of ischemic preconditioning in ovariectomized rat heart.
Vishwakarma VK; Goyal A; Gupta JK; Upadhyay PK; Yadav HN
Hum Exp Toxicol; 2018 Jul; 37(7):704-713. PubMed ID: 28920462
[TBL] [Abstract][Full Text] [Related]
15. Modulation of cardioprotective effect of ischemic pre- and postconditioning in the hyperhomocysteinemic rat heart.
Balakumar P; Rohilla A; Singh G; Singh K; Singh M
Methods Find Exp Clin Pharmacol; 2009 Mar; 31(2):71-9. PubMed ID: 19455261
[TBL] [Abstract][Full Text] [Related]
16. Mitochondria and GSK-3beta in cardioprotection against ischemia/reperfusion injury.
Miura T; Tanno M
Cardiovasc Drugs Ther; 2010 Jun; 24(3):255-63. PubMed ID: 20490903
[TBL] [Abstract][Full Text] [Related]
17. GSK-3β at the crossroads in the signalling of heart preconditioning: implication of mTOR and Wnt pathways.
Vigneron F; Dos Santos P; Lemoine S; Bonnet M; Tariosse L; Couffinhal T; Duplaà C; Jaspard-Vinassa B
Cardiovasc Res; 2011 Apr; 90(1):49-56. PubMed ID: 21233250
[TBL] [Abstract][Full Text] [Related]
18. Abrogated cardioprotective effect of ischemic preconditioning in ovariectomized rat heart.
Goyal A; Semwal BC; Yadav HN
Hum Exp Toxicol; 2016 Jun; 35(6):644-53. PubMed ID: 26264742
[TBL] [Abstract][Full Text] [Related]
19. Morphine preconditioning confers cardioprotection in doxorubicin-induced failing rat hearts via ERK/GSK-3β pathway independent of PI3K/Akt.
He SF; Jin SY; Wu H; Wang B; Wu YX; Zhang SJ; Irwin MG; Wong TM; Zhang Y
Toxicol Appl Pharmacol; 2015 Nov; 288(3):349-58. PubMed ID: 26296503
[TBL] [Abstract][Full Text] [Related]
20. Sevoflurane confers additive cardioprotection to ethanol preconditioning associated with enhanced phosphorylation of glycogen synthase kinase-3β and inhibition of mitochondrial permeability transition pore opening.
Onishi A; Miyamae M; Inoue H; Kaneda K; Okusa C; Inamura Y; Shiomi M; Koshinuma S; Momota Y; Figueredo VM
J Cardiothorac Vasc Anesth; 2013 Oct; 27(5):916-24. PubMed ID: 23266287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
